Zhifeng Ning

750 total citations
18 papers, 569 citations indexed

About

Zhifeng Ning is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Zhifeng Ning has authored 18 papers receiving a total of 569 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Zhifeng Ning's work include Cancer Cells and Metastasis (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Virus-based gene therapy research (2 papers). Zhifeng Ning is often cited by papers focused on Cancer Cells and Metastasis (3 papers), Histone Deacetylase Inhibitors Research (3 papers) and Virus-based gene therapy research (2 papers). Zhifeng Ning collaborates with scholars based in China and United States. Zhifeng Ning's co-authors include Hao Zhang, Dianzheng Zhang, Meichun Hu, Lu Wang, Kai Li, Yuping Chen, Zhimeng Yao, Shuhong Wang, Xiao Xiong and Jing Wang and has published in prestigious journals such as PLoS ONE, International Journal of Molecular Sciences and Cancer Letters.

In The Last Decade

Zhifeng Ning

17 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Zhifeng Ning China	14	379	174	138	84	80	18	569
Yiting Tang China	17	637 1.7×	105 0.6×	301 2.2×	120 1.4×	82 1.0×	31	965
Junhui Yu China	12	533 1.4×	98 0.6×	127 0.9×	159 1.9×	136 1.7×	25	685
Jufang Chi China	15	288 0.8×	86 0.5×	79 0.6×	47 0.6×	77 1.0×	26	579
Xiaoming Huang China	14	329 0.9×	119 0.7×	166 1.2×	107 1.3×	64 0.8×	54	616
Jiaming Zhu China	17	482 1.3×	67 0.4×	387 2.8×	50 0.6×	67 0.8×	30	785
Huaxin Zhou China	16	397 1.0×	150 0.9×	151 1.1×	166 2.0×	104 1.3×	42	756
Shubo Zhao Germany	9	607 1.6×	106 0.6×	103 0.7×	193 2.3×	60 0.8×	10	778
Francesca Conserva Italy	14	449 1.2×	115 0.7×	244 1.8×	52 0.6×	40 0.5×	26	774
Patrycja Sosińska Poland	15	244 0.6×	127 0.7×	87 0.6×	77 0.9×	69 0.9×	29	564
Suresh Guruswamy United States	11	411 1.1×	140 0.8×	54 0.4×	48 0.6×	66 0.8×	16	608

Countries citing papers authored by Zhifeng Ning

Since Specialization

Citations

This map shows the geographic impact of Zhifeng Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhifeng Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhifeng Ning more than expected).

Fields of papers citing papers by Zhifeng Ning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhifeng Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhifeng Ning. The network helps show where Zhifeng Ning may publish in the future.

Co-authorship network of co-authors of Zhifeng Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Zhifeng Ning. A scholar is included among the top collaborators of Zhifeng Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhifeng Ning. Zhifeng Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Liu, Yan, et al.. (2025). Trends in food protein-induced allergic proctocolitis (FPIAP): Mechanisms and treatment targeting gut microbiome. Clinics and Research in Hepatology and Gastroenterology. 49(7). 102634–102634.

Li, Lin, Yuan Chen, Yan Liu, et al.. (2024). Gut microbiota: Implications in pathogenesis and therapy to cardiovascular disease (Review). Experimental and Therapeutic Medicine. 28(5). 427–427. 5 indexed citations

Fu, Yixiao, et al.. (2024). Antitumor properties of griseofulvin and its toxicity. Frontiers in Pharmacology. 15. 1459539–1459539. 5 indexed citations

Li, Lin, Qing Wu, Feifei Lu, et al.. (2023). Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Frontiers in Oncology. 13. 66 indexed citations

Li, Yan, Yen‐An Chen, Pei Liu, et al.. (2022). ALDH1: A potential therapeutic target for cancer stem cells in solid tumors. Frontiers in Oncology. 12. 1026278–1026278. 66 indexed citations

Zhou, Hong, Yanling Sun, Long Wang, et al.. (2022). Metformin: A promising drug for human cancers (Review). Oncology Letters. 24(1). 204–204. 27 indexed citations

Yan, Hongzhu, Yanling Sun, Meichun Hu, et al.. (2020). PELP1 Suppression Inhibits Gastric Cancer Through Downregulation of c-Src-PI3K-ERK Pathway. Frontiers in Oncology. 9. 1423–1423. 14 indexed citations

Wang, Lu, Kai Li, Zhimeng Yao, et al.. (2019). Metformin induces human esophageal carcinoma cell pyroptosis by targeting the miR-497/PELP1 axis. Cancer Letters. 450. 22–31. 188 indexed citations

Bao, Cuiyu, Wenjing Li, Hui He, et al.. (2019). Cancer stem cells in esophageal squamous cell cancer (Review). Oncology Letters. 18(5). 5022–5032. 15 indexed citations

10.

Ning, Zhifeng, et al.. (2018). Neuregulin1 acts as a suppressor in human lung adenocarcinoma via AKT and ERK1/2 pathway. Journal of Thoracic Disease. 10(6). 3166–3179. 14 indexed citations

11.

Wang, Yang, Sheng Hu, Han Hu, et al.. (2018). Stability and anti-tumor effect of oncolytic herpes simplex virus type 2. Oncotarget. 9(37). 24672–24683. 21 indexed citations

12.

Shen, Jia, et al.. (2018). Isomangiferin, a Novel Potent Vascular Endothelial Growth Factor Receptor 2 Kinase Inhibitor, Suppresses Breast Cancer Growth, Metastasis and Angiogenesis. Journal of Breast Cancer. 21(1). 11–11. 23 indexed citations

13.

Ning, Zhifeng, et al.. (2017). Corepressor metastasis-associated protein 3 modulates epithelial-to-mesenchymal transition and metastasis. Chinese Journal of Cancer. 36(1). 28–28. 13 indexed citations

14.

Ning, Zhifeng, Jinfeng Gan, Chaoying Chen, Dianzheng Zhang, & Hao Zhang. (2014). Molecular functions and significance of the MTA family in hormone-independent cancer. Cancer and Metastasis Reviews. 33(4). 901–919. 17 indexed citations

15.

Zhao, Qian, Wen Zhang, Zhifeng Ning, et al.. (2014). A Novel Oncolytic Herpes Simplex Virus Type 2 Has Potent Anti-Tumor Activity. PLoS ONE. 9(3). e93103–e93103. 39 indexed citations

16.

Ning, Zhifeng, Hua Zhu, Feifei Li, et al.. (2014). Tumor suppression by miR-31 in esophageal carcinoma is p21-dependent. Genes & Cancer. 5(11-12). 436–444. 16 indexed citations

17.

Zhang, Yuling, Hongzheng Ren, Lu Wang, et al.. (2014). Clinical Impact of Tumor-Infiltrating Inflammatory Cells in Primary Small Cell Esophageal Carcinoma. International Journal of Molecular Sciences. 15(6). 9718–9734. 26 indexed citations

18.

Ning, Zhifeng, Youzhi Zhang, Hanwei Chen, et al.. (2014). PELP1 Suppression Inhibits Colorectal Cancer through c-Src Downregulation. Oxidative Medicine and Cellular Longevity. 2014. 1–9. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact